We have located links that may give you full text access.
A Study on the Effects of Esketamine Combined with Comprehensive Nursing Intervention on Postoperative Pain, Postpartum Depression, and Quality of Life in Women Undergoing Cesarean Section.
Alternative Therapies in Health and Medicine 2024 April 27
OBJECTIVE: The objective of this study was to investigate and analyze the effects of esketamine combined with comprehensive nursing intervention on postoperative pain, postpartum depression, and quality of life in women undergoing cesarean section.
METHODS: This study included 140 parturients who underwent cesarean section in The Second Hospital of Dalian Medical University (from May 2021 to May 2022). The participants were divided into two groups: the control group and the study group, based on random allocation. The control group received traditional treatment and routine nursing care, while the study group received esketamine combined with comprehensive nursing intervention. Postoperative pain, postpartum depression, and quality of life were assessed using the Visual Analog Scale (VAS), Edinburgh Postnatal Depression Scale (EPDS), and SF-36 questionnaire, respectively.
RESULTS: The two groups had no significant differences in baseline data (P > .05). The postoperative VAS scores of the study group (1.86 ± 0.65) were lower than those of the control group (3.04 ± 0.79) (P < .05). The postoperative EPDS scores of the study group (5.23 ± 1.07) were lower than those of the control group (8.11 ± 1.84) (P < .05). The postoperative physiological recovery of the study group was superior to that of the control group (P < .05). The postoperative SF-36 scores of the study group were higher than those of the control group (P < .05).
PRACTICAL IMPLICATIONS: The combined use of esketamine and comprehensive nursing in cesarean sections offers practical benefits for patient care. Notably, it leads to reduced postoperative pain, as indicated by lower VAS scores, promising improved satisfaction for parturients. The intervention also demonstrates a positive impact on postpartum mental health, with lower EPDS scores suggesting potential benefits in alleviating depression. Moreover, the observed accelerated physiological recovery in the study group, along with shorter hospital stays, signifies efficiency gains in healthcare delivery. This not only optimizes resource utilization but also contributes to an enhanced overall recovery experience for women undergoing cesarean sections.
CONCLUSION: The application of esketamine combined with comprehensive nursing intervention after cesarean section has a positive impact on the pain relief, postpartum depression, and quality of life of parturients. This study provides new insights and guidance for clinical practice, potentially enhancing the postoperative experience of women undergoing cesarean section. These findings furnish healthcare professionals with valuable insights and guidance, fostering a nuanced and improved standard of care in obstetric practices.
METHODS: This study included 140 parturients who underwent cesarean section in The Second Hospital of Dalian Medical University (from May 2021 to May 2022). The participants were divided into two groups: the control group and the study group, based on random allocation. The control group received traditional treatment and routine nursing care, while the study group received esketamine combined with comprehensive nursing intervention. Postoperative pain, postpartum depression, and quality of life were assessed using the Visual Analog Scale (VAS), Edinburgh Postnatal Depression Scale (EPDS), and SF-36 questionnaire, respectively.
RESULTS: The two groups had no significant differences in baseline data (P > .05). The postoperative VAS scores of the study group (1.86 ± 0.65) were lower than those of the control group (3.04 ± 0.79) (P < .05). The postoperative EPDS scores of the study group (5.23 ± 1.07) were lower than those of the control group (8.11 ± 1.84) (P < .05). The postoperative physiological recovery of the study group was superior to that of the control group (P < .05). The postoperative SF-36 scores of the study group were higher than those of the control group (P < .05).
PRACTICAL IMPLICATIONS: The combined use of esketamine and comprehensive nursing in cesarean sections offers practical benefits for patient care. Notably, it leads to reduced postoperative pain, as indicated by lower VAS scores, promising improved satisfaction for parturients. The intervention also demonstrates a positive impact on postpartum mental health, with lower EPDS scores suggesting potential benefits in alleviating depression. Moreover, the observed accelerated physiological recovery in the study group, along with shorter hospital stays, signifies efficiency gains in healthcare delivery. This not only optimizes resource utilization but also contributes to an enhanced overall recovery experience for women undergoing cesarean sections.
CONCLUSION: The application of esketamine combined with comprehensive nursing intervention after cesarean section has a positive impact on the pain relief, postpartum depression, and quality of life of parturients. This study provides new insights and guidance for clinical practice, potentially enhancing the postoperative experience of women undergoing cesarean section. These findings furnish healthcare professionals with valuable insights and guidance, fostering a nuanced and improved standard of care in obstetric practices.
Full text links
Related Resources
Trending Papers
Advances in Clinical Cardiology 2023: A Summary of Key Clinical Trials.Advances in Therapy 2024 May 15
Nutrition in the intensive care unit: from the acute phase to beyond.Intensive Care Medicine 2024 May 22
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment.Cardiac Failure Review 2024
Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.Cochrane Database of Systematic Reviews 2024 May 22
Bronchiectasis management in adults: state of the art and future directions.European Respiratory Journal 2024 May 24
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 2024 April 5
Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease.Biomedicines 2024 April 31
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app